Market Cap 4 Billion
Repligen Corp is a bioprocessing company that develops, produces and commercializes innovative biologic drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.
EPS 0.17 P/E Ratio 119.64
Previous Fri, Apr 26, 2019
Latest Thu, Aug 1, 2019 (79 days ago) Price +0.00%
Pay Date --
Dec 24, 2018
Aug 1, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.